These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 23459020)
21. Tumor cells-specific targeting delivery achieved by A54 peptide functionalized polymeric micelles. Du YZ; Cai LL; Liu P; You J; Yuan H; Hu FQ Biomaterials; 2012 Dec; 33(34):8858-67. PubMed ID: 22959183 [TBL] [Abstract][Full Text] [Related]
22. Enhanced transdermal lymphatic drug delivery of hyaluronic acid modified transfersomes for tumor metastasis therapy. Kong M; Hou L; Wang J; Feng C; Liu Y; Cheng X; Chen X Chem Commun (Camb); 2015 Jan; 51(8):1453-6. PubMed ID: 25493296 [TBL] [Abstract][Full Text] [Related]
23. Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles. Dreis S; Rothweiler F; Michaelis M; Cinatl J; Kreuter J; Langer K Int J Pharm; 2007 Aug; 341(1-2):207-14. PubMed ID: 17478065 [TBL] [Abstract][Full Text] [Related]
24. Phenylboronic acid conjugated to doxorubicin nanocomplexes as an anti-cancer drug delivery system in hepatocellular carcinoma. Kang BY; Hur W; Kim SM; Kim S; Lee J; Tak E; Kim WJ; Chun HJ; Yoon SK Nanomedicine; 2021 Jun; 34():102389. PubMed ID: 33753281 [TBL] [Abstract][Full Text] [Related]
25. [Effect of immunonanoparticles loaded with adriamycin on multidrug-resistant liver cancer in nude mice]. Kan HP; Wang Y; Tan YF; Zhou J Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug; 29(8):1617-9. PubMed ID: 19726309 [TBL] [Abstract][Full Text] [Related]
26. Heparin-deoxycholic acid chemical conjugate as an anticancer drug carrier and its antitumor activity. Park K; Lee GY; Kim YS; Yu M; Park RW; Kim IS; Kim SY; Byun Y J Control Release; 2006 Sep; 114(3):300-6. PubMed ID: 16884806 [TBL] [Abstract][Full Text] [Related]
27. Green preparation process, characterization and antitumor effects of doxorubicin-BSA-dextran nanoparticles. Deng W; Li J; Yao P; He F; Huang C Macromol Biosci; 2010 Oct; 10(10):1224-34. PubMed ID: 20602420 [TBL] [Abstract][Full Text] [Related]
28. Phenylboronic Acid-Mediated Tumor Targeting of Chitosan Nanoparticles. Wang X; Tang H; Wang C; Zhang J; Wu W; Jiang X Theranostics; 2016; 6(9):1378-92. PubMed ID: 27375786 [TBL] [Abstract][Full Text] [Related]
29. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model. Wong HL; Rauth AM; Bendayan R; Wu XY Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986 [TBL] [Abstract][Full Text] [Related]
30. Anti-tumor drug delivery of pH-sensitive poly(ethylene glycol)-poly(L-histidine-)-poly(L-lactide) nanoparticles. Liu R; Li D; He B; Xu X; Sheng M; Lai Y; Wang G; Gu Z J Control Release; 2011 May; 152(1):49-56. PubMed ID: 21397642 [TBL] [Abstract][Full Text] [Related]
31. Folic acid-conjugated protein cages of a plant virus: a novel delivery platform for doxorubicin. Ren Y; Wong SM; Lim LY Bioconjug Chem; 2007; 18(3):836-43. PubMed ID: 17407258 [TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo antitumor effects of doxorubicin loaded with bacterial magnetosomes (DBMs) on H22 cells: the magnetic bio-nanoparticles as drug carriers. Sun JB; Duan JH; Dai SL; Ren J; Zhang YD; Tian JS; Li Y Cancer Lett; 2007 Dec; 258(1):109-17. PubMed ID: 17920762 [TBL] [Abstract][Full Text] [Related]
33. Functionalized polymersomes with outlayered polyelectrolyte gels for potential tumor-targeted delivery of multimodal therapies and MR imaging. Chiang WH; Huang WC; Chang CW; Shen MY; Shih ZF; Huang YF; Lin SC; Chiu HC J Control Release; 2013 Jun; 168(3):280-8. PubMed ID: 23562635 [TBL] [Abstract][Full Text] [Related]
34. Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin. Cho HJ; Yoon IS; Yoon HY; Koo H; Jin YJ; Ko SH; Shim JS; Kim K; Kwon IC; Kim DD Biomaterials; 2012 Feb; 33(4):1190-200. PubMed ID: 22074664 [TBL] [Abstract][Full Text] [Related]
35. Blood Exosomes Endowed with Magnetic and Targeting Properties for Cancer Therapy. Qi H; Liu C; Long L; Ren Y; Zhang S; Chang X; Qian X; Jia H; Zhao J; Sun J; Hou X; Yuan X; Kang C ACS Nano; 2016 Mar; 10(3):3323-33. PubMed ID: 26938862 [TBL] [Abstract][Full Text] [Related]
36. Cisplatin-loaded gelatin-poly(acrylic acid) nanoparticles: synthesis, antitumor efficiency in vivo and penetration in tumors. Ding D; Zhu Z; Liu Q; Wang J; Hu Y; Jiang X; Liu B Eur J Pharm Biopharm; 2011 Sep; 79(1):142-9. PubMed ID: 21272637 [TBL] [Abstract][Full Text] [Related]
37. Delivery of hydrophilic drug doxorubicin hydrochloride-targeted liver using apoAI as carrier. Yuan Y; Wang W; Wang B; Zhu H; Zhang B; Feng M J Drug Target; 2013 May; 21(4):367-74. PubMed ID: 23600747 [TBL] [Abstract][Full Text] [Related]
38. Influence of doxorubicin inclusion into phospholipid nanoformulation on its antitumor activity in mice: increased efficiency for resistant tumor model. Zykova MG; Medvedeva NV; Torkhovskaya TI; Tikhonova EG; Prozorovskii VN; Zakharova TS; Ipatova OM Exp Oncol; 2012 Dec; 34(4):323-6. PubMed ID: 23302989 [TBL] [Abstract][Full Text] [Related]
39. The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles. Min KH; Lee HJ; Kim K; Kwon IC; Jeong SY; Lee SC Biomaterials; 2012 Aug; 33(23):5788-97. PubMed ID: 22591612 [TBL] [Abstract][Full Text] [Related]
40. Mucin-controlled drug release from mucoadhesive phenylboronic acid-rich nanoparticles. Li C; Liu Z; Yan X; Lu W; Liu Y Int J Pharm; 2015 Feb; 479(1):261-4. PubMed ID: 25528296 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]